About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Nad+ Activates Immune Responses Against Lethal Infections

by Shravanthi Vikram on February 26, 2018 at 2:50 PM
Font : A-A+

Nad+ Activates Immune Responses Against Lethal Infections

Nicotinamide adenine dinucleotide (NAD+), a natural occurring cell molecule when administered into the body activates the cellular and molecular pathway that regulates the CD4+ T cells, finds a research team at Brigham and Women's Hospital (BWH). The NAD+ shuts off the capacity of the dendrite and macrophage cells which are responsible for fate of CD4+ T cells and regulate them through the mast cells. This helps in treating disease that rise due to the alterations occurring in CD4+T cells. The findings of the study are published in the Journal of Allergy and Clinical Immunology.

"This is a novel cellular and molecular pathway that is distinct from the two major pathways that were previously known. Since it is distinct and since it has the ability to regulate the immune system systemically, we can use it as an alternative to bypass the current pathways," said Abdallah ElKhal, PhD, BWH Department of Surgery, senior study author.

Advertisement


CD4+ T helper cells and dendritic cells play a central role in immunity. Alterations or aberrant dendritic cells and T cell responses can lead to many health conditions including autoimmune diseases, infections, allergy, primary immunodeficiencies and cancer.

As of today, two major pathways have been described to regulate CD4+ T cell response. The first pathway was described by Peter C. Doherty and Rolf M. Zinkernagel (1996 Nobel prize winners) showing the requirement of MHC-TCR signaling machinery. More recently, a second mechanism involving the Pathogen or Damage Associated Molecular Patterns (PAMPs or DAMPs) was unraveled by Bruce A. Beutler and Jules A. Hoffmann (2011 Nobel Prize winners). Of importance, both pathways require antigen presenting cells (APCs) in particular dendritic cells (DCs) or macrophages (Mö). Elkhal's novel pathway is distinct from the two previous ones and may offer a path forward for novel therapeutic approaches.
Advertisement

For the current study, BWH researchers performed pre-clinical trials using an experimental infection model. They showed that mast cell-mediated CD4+ T cell response protects against lethal doses of infection (Listeria monocytogenes). Mice treated with NAD+ had a dramatically increased survival rate when compared to the non-treated group.

"Collectively, our study unravels a novel cellular and molecular pathway that regulates innate and adaptive immunity via MCs, exclusively, and underscores the therapeutic potential of NAD+ in the context of a myriad of diseases including autoimmune diseases, hemophilia, primary immunodeficiencies and antimicrobial resistance," said Elkhal.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Myasthenia Gravis 

Recommended Reading
Platelets’ Hidden Role in Immunity Discovered
Unexpected role of platelets in immune response discovered. Beyond coagulation platelets act as the ...
'Great Escape' Helps Uncover Autoimmunity
The 'Great Escape' moment may one day prove to be the crucial trigger for autoimmune diseases....
Vitamin A Balance Influences Protein That Protects Gut Immunity
ISX, a protein molecule turns on and off genes involved in the pathway based on beta-carotene ......
Autoimmunity may be the Cause of the Mysterious Nerve Damaging Disorder
Immunoglobulin infusions improve pain and function in 75 percent of patients thought to have ......
Myasthenia Gravis
Myasthenia gravis is the commonest disorder of neuromuscular transmission. Autoimmune myasthenia gra...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)